Status:
COMPLETED
COVID-19 Testing Pilot Study
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
Benjamin S. Abella, MD, MPhil
Marcelo Der Torossian Torres, Ph.D.
Conditions:
Diagnostic Test, Routine
Coronavirus
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the reliability of a low-cost rapid diagnostic test for COVID-19. The method of the testing procedure uses electrochemistry to detect COVID-19 spike proteins ...
Eligibility Criteria
Inclusion
- The subject must be an adult (age\>17) and either sex.
- Written informed consent must be obtained prior to study enrollment.
- a. A subject who is eighteen (18) years or older must be willing to give written informed consent and must agree to comply with study procedures.
- Subject must be able to read and write in English.
Exclusion
- The subject is currently receiving or has received within the past thirty (30) days of the study visit an experimental biologic, drug, or device including either treatment or therapy.
- The subject has previously participated in this research study.
Key Trial Info
Start Date :
January 5 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 12 2021
Estimated Enrollment :
326 Patients enrolled
Trial Details
Trial ID
NCT04843878
Start Date
January 5 2021
End Date
March 12 2021
Last Update
April 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, United States, 19104